Royce & Associates’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,851
Closed -$33.1K 945
2023
Q2
$33.1K Buy
+22,851
New +$33.1K ﹤0.01% 910